WELL Health USA

WELL Health USA, formerly known as CRH Medical Corporation, operates as a key business unit of its parent company, WELL Health Technologies Corp. The company was originally incorporated as Medsurge Medical Products Corp. in 2001, rebranding to CRH Medical Corporation in 2006. A significant milestone occurred in April 2021, when WELL Health Technologies acquired CRH Medical for an approximate transaction value of $372.9 million, integrating it as a wholly-owned subsidiary. This acquisition was a strategic move for WELL to expand its footprint into the U.S. healthcare market, leveraging CRH's established presence. In July 2023, CRH Medical was rebranded to WELL Health USA to better align with the parent company's mission of tech-enabling healthcare providers in the United States.

The business focuses on providing services and products to the gastroenterology (GI) community across the United States. A core part of its business since 2014 is providing full-service gastroenterology anesthesia for patients undergoing endoscopic procedures in ambulatory surgical centers (ASCs). The company serves numerous ASCs and GI clinics across many states, partnering with thousands of gastroenterologists. Revenue is generated through these anesthesia services and the sale of its proprietary medical product. Following its acquisition, WELL Health USA now functions as the center of the parent company's U.S. operations, aiming to digitize and modernize healthcare businesses while providing shared corporate services like HR, marketing, and M&A support to its portfolio companies.

WELL Health USA's flagship product is the CRH O'Regan System, a disposable, single-use hemorrhoid banding device. Invented in 1997 by Dr. Patrick J. O'Regan, this FDA-approved technology is designed for the non-surgical treatment of internal hemorrhoids. The system uses a gentle suction method to apply a small rubber band to the base of a hemorrhoid, which cuts off the blood supply, causing the hemorrhoid to shrink and fall off within a few days. This procedure is noted for being quick, often taking less than a minute, and can be performed in a physician's office without sedation or extensive preparation. The benefits highlighted include a high effectiveness rate of over 99%, a minimal complication rate, and a low recurrence rate compared to traditional banding methods. The company distributes the CRH O'Regan System as a complete package that includes the device, treatment protocols, and operational and marketing support directly to gastroenterology practices.

Keywords: gastroenterology services, anesthesia management, ambulatory surgical centers, medical device, hemorrhoid treatment, CRH O'Regan System, non-surgical procedure, healthcare provider services, physician support, medical products, GI clinics, endoscopic procedures, healthcare technology, patient services, US healthcare market, clinical support, medical billing, practice management, healthcare acquisitions, digital health integration